Congress·In Committee·H.R. 7528

GAP Supply Act

Drug Shortages: Extending Supply from Specialized Pharmacies

Feb 12·View on Congress.gov·Read full text

Next up: A house committee

The GAP Supply Act is currently sitting in the House Committee on Energy and Commerce. No action has been taken on this bill since February 11, 2026. Because the committee has not held a vote or meeting in four months, the bill is not moving forward.

Legislative Progress

House

Senate

President

Law

Key Points

This bill aims to keep medicine on the shelves during national shortages. It allows specialized pharmacies that make large batches of medicine to continue producing and shipping drugs for 180 days after a shortage is first reported.
Currently, these pharmacies have very limited time to help fill the gap when a major drug manufacturer stops production. This change gives them a six-month window to provide a steady supply to hospitals and doctors' offices.
By extending this timeframe, the policy helps ensure that patients do not lose access to important treatments while the government and big companies work to fix long-term supply chain problems.

Impact Analysis

Govbase has not yet run an impact analysis on this legislation.

Milestones

2 milestones2 actions

Feb 12, 2026House

Referred to the House Committee on Energy and Commerce.

Feb 12, 2026

Introduced in House

The bill was officially filed and given a number. It now enters the legislative queue.

No votes, news coverage, or related bills recorded for this bill yet.

Source Information

Document Type

Congressional Bill

Official Title

GAP Supply Act

Bill NumberHR 7528

Congress119th Congress

ChamberHouse of Representatives

Latest ActionReferred to the House Committee on Energy and Commerce.

Data Sources

Congress.gov

Official legislative information

Read Full Bill Text

Sponsor

Analysis generated by AI. Always verify with official sources.